Peptide YY and gallbladder contraction. Studies in vivo and in vitro

Felix Lluis, Masaki Fujimura, Janos Lonovics, Yan Shi Guo, Guillermo Gomez, George H. Greeley, Courtney Townsend, James C. Thompson

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The purpose of this study was to examine the effect of peptide YY on contraction of the gallbladder in vivo and in vitro and on contraction of the sphincter of Oddi in vitro. In conscious dogs that were prepared with strain-gauge force transducers implanted in the gallbladder wall, peptide YY (400 ng/kg, bolus; 800 pmol/kg · h, infusion) did not affect the resting contractile pattern of the gallbladder, nor did it inhibit cholecystokinin-octapeptide (CCK-8)-stimulated gallbladder contraction. In contrast, the cholecystokinin antagonist proglumide (5, 10, 20, 40, or 80 mg/kg), given in vivo, inhibited CCK-8-stimulated gallbladder contraction in a dose-related manner. The highest dose of proglumide (80 mg/kg) completely abolished contraction of the gallbladder stimulated by CCK-8. In vitro studies showed that peptide YY (0.25, 0.5, or 1 μg/ml) did not affect the resting tension of rabbit gallbladder strips, and it did not inhibit CCK-8-stimulated contraction of gallbladder strips. Proglumide (0.4, 0.8, 1.6, or 3.2 mg/ml) inhibited CCK-8-stimulated tension of gallbladder strips in a dose-related manner. Peptide YY and CCK-8 had no effect on the motility of the canine sphincter of Oddi in vitro, whereas acetylcholine caused contraction and adrenergic agonists caused relaxation. These results suggest that peptide YY and pancreatone (a peptidelike substance, extracted from ileal and colonic mucosa, that inhibits CCK-8-stimulated gallbladder contraction in vivo) do not appear to be identical.

Original languageEnglish
Pages (from-to)1441-1446
Number of pages6
JournalGastroenterology
Volume94
Issue number6
StatePublished - 1988

Fingerprint

Peptide YY
Sincalide
Gallbladder
Proglumide
Sphincter of Oddi
In Vitro Techniques
Adrenergic Agonists
Cholecystokinin
Transducers
Acetylcholine
Canidae
Mucous Membrane
Dogs

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Lluis, F., Fujimura, M., Lonovics, J., Guo, Y. S., Gomez, G., Greeley, G. H., ... Thompson, J. C. (1988). Peptide YY and gallbladder contraction. Studies in vivo and in vitro. Gastroenterology, 94(6), 1441-1446.

Peptide YY and gallbladder contraction. Studies in vivo and in vitro. / Lluis, Felix; Fujimura, Masaki; Lonovics, Janos; Guo, Yan Shi; Gomez, Guillermo; Greeley, George H.; Townsend, Courtney; Thompson, James C.

In: Gastroenterology, Vol. 94, No. 6, 1988, p. 1441-1446.

Research output: Contribution to journalArticle

Lluis, F, Fujimura, M, Lonovics, J, Guo, YS, Gomez, G, Greeley, GH, Townsend, C & Thompson, JC 1988, 'Peptide YY and gallbladder contraction. Studies in vivo and in vitro', Gastroenterology, vol. 94, no. 6, pp. 1441-1446.
Lluis F, Fujimura M, Lonovics J, Guo YS, Gomez G, Greeley GH et al. Peptide YY and gallbladder contraction. Studies in vivo and in vitro. Gastroenterology. 1988;94(6):1441-1446.
Lluis, Felix ; Fujimura, Masaki ; Lonovics, Janos ; Guo, Yan Shi ; Gomez, Guillermo ; Greeley, George H. ; Townsend, Courtney ; Thompson, James C. / Peptide YY and gallbladder contraction. Studies in vivo and in vitro. In: Gastroenterology. 1988 ; Vol. 94, No. 6. pp. 1441-1446.
@article{a2ffba5108874cc7871b1dc1d13d0ae3,
title = "Peptide YY and gallbladder contraction. Studies in vivo and in vitro",
abstract = "The purpose of this study was to examine the effect of peptide YY on contraction of the gallbladder in vivo and in vitro and on contraction of the sphincter of Oddi in vitro. In conscious dogs that were prepared with strain-gauge force transducers implanted in the gallbladder wall, peptide YY (400 ng/kg, bolus; 800 pmol/kg · h, infusion) did not affect the resting contractile pattern of the gallbladder, nor did it inhibit cholecystokinin-octapeptide (CCK-8)-stimulated gallbladder contraction. In contrast, the cholecystokinin antagonist proglumide (5, 10, 20, 40, or 80 mg/kg), given in vivo, inhibited CCK-8-stimulated gallbladder contraction in a dose-related manner. The highest dose of proglumide (80 mg/kg) completely abolished contraction of the gallbladder stimulated by CCK-8. In vitro studies showed that peptide YY (0.25, 0.5, or 1 μg/ml) did not affect the resting tension of rabbit gallbladder strips, and it did not inhibit CCK-8-stimulated contraction of gallbladder strips. Proglumide (0.4, 0.8, 1.6, or 3.2 mg/ml) inhibited CCK-8-stimulated tension of gallbladder strips in a dose-related manner. Peptide YY and CCK-8 had no effect on the motility of the canine sphincter of Oddi in vitro, whereas acetylcholine caused contraction and adrenergic agonists caused relaxation. These results suggest that peptide YY and pancreatone (a peptidelike substance, extracted from ileal and colonic mucosa, that inhibits CCK-8-stimulated gallbladder contraction in vivo) do not appear to be identical.",
author = "Felix Lluis and Masaki Fujimura and Janos Lonovics and Guo, {Yan Shi} and Guillermo Gomez and Greeley, {George H.} and Courtney Townsend and Thompson, {James C.}",
year = "1988",
language = "English",
volume = "94",
pages = "1441--1446",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Peptide YY and gallbladder contraction. Studies in vivo and in vitro

AU - Lluis, Felix

AU - Fujimura, Masaki

AU - Lonovics, Janos

AU - Guo, Yan Shi

AU - Gomez, Guillermo

AU - Greeley, George H.

AU - Townsend, Courtney

AU - Thompson, James C.

PY - 1988

Y1 - 1988

N2 - The purpose of this study was to examine the effect of peptide YY on contraction of the gallbladder in vivo and in vitro and on contraction of the sphincter of Oddi in vitro. In conscious dogs that were prepared with strain-gauge force transducers implanted in the gallbladder wall, peptide YY (400 ng/kg, bolus; 800 pmol/kg · h, infusion) did not affect the resting contractile pattern of the gallbladder, nor did it inhibit cholecystokinin-octapeptide (CCK-8)-stimulated gallbladder contraction. In contrast, the cholecystokinin antagonist proglumide (5, 10, 20, 40, or 80 mg/kg), given in vivo, inhibited CCK-8-stimulated gallbladder contraction in a dose-related manner. The highest dose of proglumide (80 mg/kg) completely abolished contraction of the gallbladder stimulated by CCK-8. In vitro studies showed that peptide YY (0.25, 0.5, or 1 μg/ml) did not affect the resting tension of rabbit gallbladder strips, and it did not inhibit CCK-8-stimulated contraction of gallbladder strips. Proglumide (0.4, 0.8, 1.6, or 3.2 mg/ml) inhibited CCK-8-stimulated tension of gallbladder strips in a dose-related manner. Peptide YY and CCK-8 had no effect on the motility of the canine sphincter of Oddi in vitro, whereas acetylcholine caused contraction and adrenergic agonists caused relaxation. These results suggest that peptide YY and pancreatone (a peptidelike substance, extracted from ileal and colonic mucosa, that inhibits CCK-8-stimulated gallbladder contraction in vivo) do not appear to be identical.

AB - The purpose of this study was to examine the effect of peptide YY on contraction of the gallbladder in vivo and in vitro and on contraction of the sphincter of Oddi in vitro. In conscious dogs that were prepared with strain-gauge force transducers implanted in the gallbladder wall, peptide YY (400 ng/kg, bolus; 800 pmol/kg · h, infusion) did not affect the resting contractile pattern of the gallbladder, nor did it inhibit cholecystokinin-octapeptide (CCK-8)-stimulated gallbladder contraction. In contrast, the cholecystokinin antagonist proglumide (5, 10, 20, 40, or 80 mg/kg), given in vivo, inhibited CCK-8-stimulated gallbladder contraction in a dose-related manner. The highest dose of proglumide (80 mg/kg) completely abolished contraction of the gallbladder stimulated by CCK-8. In vitro studies showed that peptide YY (0.25, 0.5, or 1 μg/ml) did not affect the resting tension of rabbit gallbladder strips, and it did not inhibit CCK-8-stimulated contraction of gallbladder strips. Proglumide (0.4, 0.8, 1.6, or 3.2 mg/ml) inhibited CCK-8-stimulated tension of gallbladder strips in a dose-related manner. Peptide YY and CCK-8 had no effect on the motility of the canine sphincter of Oddi in vitro, whereas acetylcholine caused contraction and adrenergic agonists caused relaxation. These results suggest that peptide YY and pancreatone (a peptidelike substance, extracted from ileal and colonic mucosa, that inhibits CCK-8-stimulated gallbladder contraction in vivo) do not appear to be identical.

UR - http://www.scopus.com/inward/record.url?scp=0023875064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023875064&partnerID=8YFLogxK

M3 - Article

C2 - 3360265

AN - SCOPUS:0023875064

VL - 94

SP - 1441

EP - 1446

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 6

ER -